Filing Details
- Accession Number:
- 0001181431-14-035371
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-04 14:53:44
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-04
- Accepted Time:
- 2014-11-04 14:53:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1310132 | Roger Valine | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-03 | 12,000 | $31.32 | 28,530 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-11-03 | 4,815 | $78.07 | 23,715 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-11-03 | 7,185 | $77.85 | 16,530 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2014-11-03 | 12,000 | $0.00 | 12,000 | $31.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-06-07 | 2015-06-07 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/5/2014.
- Represents the weighted average sale price of $77.8465. The range of prices for the sale of these shares was $77.60 - $78.08, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.